REGULATION / HOW TO READ EVIDENCE
How to read a product's development status.
A promising laboratory result, a trial involving people and an authorised product are three distinct stages that must never be presented as equivalent.
The most common mistake is to compress the entire development pathway into one sentence: “research shows that it works”. Without the type and stage of research, that statement does not reveal the strength of the evidence.
Laboratory research asks whether a concept is worth studying further.
An in-vitro experiment may show an interaction with a receptor, cell or biological process. Animal models can add further information. These results matter, but they do not establish safety or efficacy in people.
ACCURATE LANGUAGE“An effect was observed in a research model” — not: “the product works in humans”.
Every clinical phase answers a different question.
An early study may focus on tolerability and how a substance behaves in the body. Later, larger studies assess efficacy, adverse effects and comparison with a control or standard treatment.
A positive result in one phase does not guarantee success in the next. Group size, study design, endpoints, observation time and the complete safety profile all matter.
Authorisation applies to a specific product and a specific use.
A regulator evaluates evidence on quality, safety and efficacy. Its decision concerns a defined product, manufacturer, manufacturing process, indication and conditions of use. It does not automatically extend to another product containing a similar molecule.
Research products, food supplements and medicinal products are governed by different requirements. Their names and statuses should not be used interchangeably.
Before believing a headline, ask four questions.
- What exactly was studied?
A molecule, formulation, device or finished product?
- In which model?
In a test tube, in animals or with human participants?
- What was the stage and outcome?
An early signal, a confirmed endpoint or a regulatory decision?
- What remains unknown?
Reliable reporting also identifies limitations and unanswered questions.
Evidence is most useful when its limits remain visible.
SUBVERIX™ separates scientific findings, technical declarations and verified product documentation so that each conclusion can be read in the correct context.
RETURN TO SCIENCE NEWS